Black and Latina women who follow guidelines on nutrition and physical activity have a lower risk of developing breast, colorectal, and other obesity-related cancers.
Improving cancer outcomes via improved prevention and early detection and treatment, and better educating oncologists to implement the latest discoveries, will be the focus of the ESMO Congress 2022.
First-line therapy for renal cell carcinoma has primarily been tyrosine kinase inhibitors that target vascular endothelial growth factor and other receptors.
The combination of a tyrosine kinase inhibitor with an immune checkpoint inhibitor significantly improved progression-free survival in patients with hepatocellular carcinoma, shows a new study.